2.2056
+0.4956
+(28.98%)
As of 2:58:41 PM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -0.24 | -0.2 | -1.27 | -0.67 |
| Low Estimate | -0.28 | -0.25 | -1.31 | -0.84 |
| High Estimate | -0.23 | -0.16 | -1.25 | -0.5 |
| Year Ago EPS | -0.19 | -0.27 | -1.05 | -1.27 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | 18.98M | 18.37M | 71.36M | 76.99M |
| Low Estimate | 18.6M | 17.5M | 71M | 75.3M |
| High Estimate | 19.2M | 19M | 71.5M | 78.8M |
| Year Ago Sales | 20.31M | 17.42M | 71.35M | 71.36M |
| Sales Growth (year/est) | -6.55% | 5.47% | 0.01% | 7.90% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.31 | -0.27 | -0.23 |
| EPS Actual | -0.19 | -0.27 | -0.33 | -0.44 |
| Difference | 0.07 | 0.04 | -0.06 | -0.21 |
| Surprise % | 27.85% | 11.96% | -22.22% | -91.30% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.2 | -1.27 | -0.67 |
| 7 Days Ago | -0.24 | -0.2 | -1.27 | -0.67 |
| 30 Days Ago | -0.07 | -0.19 | -0.88 | -0.61 |
| 60 Days Ago | -0.07 | -0.19 | -0.88 | -0.61 |
| 90 Days Ago | -0.07 | -0.19 | -0.88 | -0.61 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | -- |
| Up Last 30 Days | -- | 1 | -- | -- |
| Down Last 7 Days | -- | 2 | 1 | 1 |
| Down Last 30 Days | -- | 2 | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| STIM | -27.63% | 26.85% | -20.95% | 47.24% |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Maintains | JMP Securities: Market Outperform to Market Outperform | 8/14/2024 |
| Maintains | Canaccord Genuity: Buy to Buy | 8/13/2024 |
| Downgrade | William Blair: Outperform to Market Perform | 8/12/2024 |
| Upgrade | William Blair: Market Perform to Outperform | 5/14/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 3/6/2024 |
| Reiterates | JMP Securities: Market Outperform | 5/10/2023 |
Related Tickers
NOTV Inotiv, Inc.
4.2400
-2.97%
PRPH ProPhase Labs, Inc.
0.6490
0.00%
APDN Applied DNA Sciences, Inc.
0.1889
-4.45%
CHEK Check-Cap Ltd.
1.5450
+0.98%
AVCR.V Avricore Health Inc.
0.0650
+18.18%
XWEL XWELL, Inc.
1.3900
0.00%
ENZ Enzo Biochem, Inc.
0.6500
-4.41%
PSNL Personalis, Inc.
5.27
-5.72%
MYNZ Mainz Biomed N.V.
4.6974
+9.75%
TTOO T2 Biosystems, Inc.
0.3236
+1.13%